These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2571411

  • 1. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone).
    Weber JM, Sircar S, Horvath J, Dion P.
    Cancer Res; 1989 Nov 01; 49(21):5779-83. PubMed ID: 2571411
    [Abstract] [Full Text] [Related]

  • 2. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
    Slapak CA, Daniel JC, Levy SB.
    Cancer Res; 1990 Dec 15; 50(24):7895-901. PubMed ID: 1979251
    [Abstract] [Full Text] [Related]

  • 3. Isolation of variants resistant to methylglyoxal bis(guanylhydrazone) from adenovirus-transformed rat cells.
    Sircar S, Palkonyay L, Rodrigues M, Allaire S, Horvath J, Thirion JP, Weber J.
    Cancer Res; 1987 Mar 01; 47(5):1339-43. PubMed ID: 3815342
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM.
    Cancer Res; 1987 Oct 15; 47(20):5455-60. PubMed ID: 2888532
    [Abstract] [Full Text] [Related]

  • 5. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F, Jongsma AP, Broxterman HJ, Arceci RJ, Housman D, Scheffer GL, Riethorst A, van Groenigen M, Nieuwint AW, Joenje H.
    Cancer Res; 1990 Sep 01; 50(17):5392-8. PubMed ID: 1974823
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB, Beck WT, Trent JM.
    Cancer Res; 1988 Jan 15; 48(2):393-8. PubMed ID: 2891436
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM, Goldenberg S, Gottesman MM, Hait WN.
    Cancer Res; 1994 Feb 01; 54(3):730-7. PubMed ID: 7905786
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
    Slovak ML, Hoeltge GA, Dalton WS, Trent JM.
    Cancer Res; 1988 May 15; 48(10):2793-7. PubMed ID: 2896069
    [Abstract] [Full Text] [Related]

  • 16. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
    Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, Willingham MC.
    Mol Pharmacol; 1991 Oct 15; 40(4):490-4. PubMed ID: 1681415
    [Abstract] [Full Text] [Related]

  • 17. Normalization of epidermal growth factor receptor and transforming growth factor production in drug resistant variants derived from adenovirus transformed cells.
    Sircar S, Weber JM.
    J Cell Physiol; 1988 Mar 15; 134(3):467-72. PubMed ID: 3258314
    [Abstract] [Full Text] [Related]

  • 18. Time course of MDR gene amplification during in vivo selection for doxorubicin-resistance and during reversal in murine leukemia L 1210.
    Volm M, Mattern J, Pommerenke EW.
    Anticancer Res; 1991 Mar 15; 11(2):579-85. PubMed ID: 1676579
    [Abstract] [Full Text] [Related]

  • 19. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 15; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.